IA
ONC

IFP Advisors’s BeOne Medicines Ltd ONC Stock Holding History

IFP Advisors’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-100
Closed -$10K – 3847
2017
Q4 		$10K Buy
+100
New +$9.15K ﹤0.01% 2846

Other funds holding ONC

AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
SC
Slow Capital Greenbrae, California $857M AUM 38.3% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
WAS
WESPAC Advisors SoCal Pasadena, California $560M AUM 37.11% 1-Year Est. Return
PFA
Peak Financial Advisors Denver, Colorado $242M AUM 19.63% 1-Year Est. Return
CST
Charles Schwab Trust Henderson, Nevada $1.79B AUM 17.47% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

IFP Advisors's ONC Position: Q2 2026 in Review

IFP Advisors increased its BeOne Medicines Ltd (ONC) stake by 0.1% in Q2 2026, buying an estimated $295 and bringing the position to 1,001 shares worth $285K. The position accounts for 0.01% of the portfolio, ranked #1313.

IFP Advisors first reported a position in ONC in Q3 2017 and has held it in 34 quarters since. The position peaked at $336K in Q3 2025. 48 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • IFP Advisors held 1,001 shares of BeOne Medicines Ltd worth $285K as of Q2 2026.
  • IFP Advisors bought 1 BeOne Medicines Ltd share in Q2 2026, an estimated $295.
  • BeOne Medicines Ltd made up 0.01% of IFP Advisors's portfolio in Q2 2026, its #1313 holding.
  • IFP Advisors first reported a position in BeOne Medicines Ltd in Q3 2017 and has held it in 34 quarters since.
  • IFP Advisors's BeOne Medicines Ltd position peaked at $336K in Q3 2025.
  • 48 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.